MedTrace Logo

A Study Using 18F-FAPI PET to Evaluate Treatment Response in Pancreatic Adenocarcinoma

NCT06277206 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2024-02-26

No results posted yet for this study

Summary

To explore the potential utility of 18F-FAPI-04 PET/CT for pathologic response evaluation to systemic treatment in PDAC

Conditions

  • 18F-FAPI
  • Pancreas Adenocarcinoma
  • Systemic Treatment
  • Pathologic Response

Interventions

DIAGNOSTIC_TEST

18F-FAPI PET/CT

Enrolled patients underwent 18F-FAPI PET/CT at diagnosis. And preoperative 18F-FAPI PET/CT was completed in the patients met the criteria for conversion surgery after systemic treatment. The correlation between changes of parameters before and after treatment and pathologic response was analyzed.

Sponsors & Collaborators

  • Zhejiang University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-04
Primary Completion
2023-11-19
Completion
2024-02-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06277206 on ClinicalTrials.gov